These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 34262673)

  • 1. Extracellular vesicle-mediated endothelial apoptosis and EV-associated proteins correlate with COVID-19 disease severity.
    Krishnamachary B; Cook C; Kumar A; Spikes L; Chalise P; Dhillon NK
    J Extracell Vesicles; 2021 Jul; 10(9):e12117. PubMed ID: 34262673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Potential Role of Extracellular Vesicles in COVID-19 Associated Endothelial injury and Pro-inflammation.
    Krishnamachary B; Cook C; Spikes L; Chalise P; Dhillon NK
    medRxiv; 2020 Sep; ():. PubMed ID: 32909001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report.
    Rosell A; Havervall S; von Meijenfeldt F; Hisada Y; Aguilera K; Grover SP; Lisman T; Mackman N; Thålin C
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):878-882. PubMed ID: 33267656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential therapeutic applications of extracellular vesicles in the immunopathogenesis of COVID-19.
    Motallebnezhad M; Omraninava M; Esmaeili Gouvarchin Ghaleh H; Jonaidi-Jafari N; Hazrati A; Malekpour K; Bagheri Y; Izadi M; Ahmadi M
    Pathol Res Pract; 2023 Jan; 241():154280. PubMed ID: 36580795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19.
    Guervilly C; Bonifay A; Burtey S; Sabatier F; Cauchois R; Abdili E; Arnaud L; Lano G; Pietri L; Robert T; Velier M; Papazian L; Albanese J; Kaplanski G; Dignat-George F; Lacroix R
    Blood Adv; 2021 Feb; 5(3):628-634. PubMed ID: 33560376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic profiling of single extracellular vesicles reveals colocalization of SARS-CoV-2 with a CD81/integrin-rich EV subpopulation in sputum from COVID-19 severe patients.
    Sun R; Cai Y; Zhou Y; Bai G; Zhu A; Kong P; Sun J; Li Y; Liu Y; Liao W; Liu J; Cui N; Xiang J; Li B; Zhao J; Wu D; Ran P
    Front Immunol; 2023; 14():1052141. PubMed ID: 37251406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular Vesicles and Citrullinated Histone H3 in Coronavirus Disease 2019 Patients.
    Traby L; Kollars M; Kussmann M; Karer M; Šinkovec H; Lobmeyr E; Hermann A; Staudinger T; Schellongowski P; Rössler B; Burgmann H; Kyrle PA; Eichinger S
    Thromb Haemost; 2022 Jan; 122(1):113-122. PubMed ID: 34077977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics of extracellular vesicles in plasma reveals the characteristics and residual traces of COVID-19 patients without underlying diseases after 3 months of recovery.
    Mao K; Tan Q; Ma Y; Wang S; Zhong H; Liao Y; Huang Q; Xiao W; Xia H; Tan X; Luo P; Xu J; Long D; Jin Y
    Cell Death Dis; 2021 May; 12(6):541. PubMed ID: 34035220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early prediction of COVID-19 severity using extracellular vesicle COPB2.
    Fujita Y; Hoshina T; Matsuzaki J; Yoshioka Y; Kadota T; Hosaka Y; Fujimoto S; Kawamoto H; Watanabe N; Sawaki K; Sakamoto Y; Miyajima M; Lee K; Nakaharai K; Horino T; Nakagawa R; Araya J; Miyato M; Yoshida M; Kuwano K; Ochiya T
    J Extracell Vesicles; 2021 Jun; 10(8):e12092. PubMed ID: 34122778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of Extracellular Vesicles From SARS-CoV-2 Infected Specimens: A Safety Perspective.
    Nunez Lopez YO; Casu A; Pratley RE
    Front Immunol; 2021; 12():617042. PubMed ID: 33968019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and Extracellular Vesicles: An Intriguing Interplay.
    Pocsfalvi G; Mammadova R; Ramos Juarez AP; Bokka R; Trepiccione F; Capasso G
    Kidney Blood Press Res; 2020; 45(5):661-670. PubMed ID: 32957112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the β-catenin pathway.
    Lombardo G; Gili M; Grange C; Cavallari C; Dentelli P; Togliatto G; Taverna D; Camussi G; Brizzi MF
    Oncogene; 2018 Mar; 37(9):1175-1191. PubMed ID: 29238040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular Vesicle Associated miRNAs Regulate Signaling Pathways Involved in COVID-19 Pneumonia and the Progression to Severe Acute Respiratory Corona Virus-2 Syndrome.
    Meidert AS; Hermann S; Brandes F; Kirchner B; Buschmann D; Billaud JN; Klein M; Lindemann A; Aue E; Schelling G; Pfaffl MW; Reithmair M
    Front Immunol; 2021; 12():784028. PubMed ID: 34956213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic Profile of Procoagulant Extracellular Vesicles Reflects Complement System Activation and Platelet Hyperreactivity of Patients with Severe COVID-19.
    Moraes ECDS; Martins-Gonçalves R; da Silva LR; Mandacaru SC; Melo RM; Azevedo-Quintanilha I; Perales J; Bozza FA; Souza TML; Castro-Faria-Neto HC; Hottz ED; Bozza PT; Trugilho MRO
    Front Cell Infect Microbiol; 2022; 12():926352. PubMed ID: 35937696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating endothelial progenitors are increased in COVID-19 patients and correlate with SARS-CoV-2 RNA in severe cases.
    Mancuso P; Gidaro A; Gregato G; Raveane A; Cremonesi P; Quarna J; Caccia S; Gusso L; Rusconi S; Giacomelli A; Cogliati C; Bertolini F
    J Thromb Haemost; 2020 Oct; 18(10):2744-2750. PubMed ID: 32762140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tissue factor-positive extracellular vesicles and their association with thrombosis in different diseases.
    Hisada Y; Sachetto ATA; Mackman N
    Immunol Rev; 2022 Nov; 312(1):61-75. PubMed ID: 35708588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral Bad News Sent by EVAIL.
    Clauss M; Chelvanambi S; Cook C; ElMergawy R; Dhillon N
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34207152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome.
    Merenstein C; Liang G; Whiteside SA; Cobián-Güemes AG; Merlino MS; Taylor LJ; Glascock A; Bittinger K; Tanes C; Graham-Wooten J; Khatib LA; Fitzgerald AS; Reddy S; Baxter AE; Giles JR; Oldridge DA; Meyer NJ; Wherry EJ; McGinniss JE; Bushman FD; Collman RG
    mBio; 2021 Aug; 12(4):e0177721. PubMed ID: 34399607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue Factor and COVID-19: An Update.
    Sachetto ATA; Mackman N
    Curr Drug Targets; 2022 Nov; 23(17):1573-1577. PubMed ID: 36165519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.